Timothy Mitchison

Tim Mitchison is a leading pharmacology and systems biology researcher who harnesses systematic and quantitative methods to address problems in basic cell biology and medicine. He is currently the Hasib Sabbagh Professor of Systems Biology at Harvard Medical School, director of the Harvard Therapeutics Innovation Hub (I-Hub), and co-director of the Systems Biology Ph.D. Program.

Dr. Mitchison’s research interests span basic cell biology, chemical biology, and pharmacology. Early in his career, he worked at the National Institute for Medical Research in London and then joined the faculty at University of California, San Francisco, where he rose to professor of pharmacology. He moved to Harvard Medical School in 1997 to establish the Institute of Chemistry and Cell Biology, one of the first drug screening platforms in academia, and in 2004 he helped Marc Kirchner establish the new Department of Systems Biology. His professional honors include election to the U.K. Royal Society, the U.S. National Academy, and serving as President of the American Society of Cell Biology. He is a co-founder of Ribon Therapeutics and a member of the Scientific Advisory Board of the Innovative Protein Institute (IPI). He received his B.A. in biochemistry from Oxford University, England, and his Ph.D. in biochemistry and biophysics from UCSF.